| DAY 1 | WEDNESDAY | 16 NOVEMBER 2022 | ||
TIME |
SESSION # |
STATUS |
3.00 PM - 3.30 PM |
Opening Session |
Welcome Remarks: Ms. Ambika Sharma, Managing Director, USIBC India Keynote: Ms. Judith Ravin, U.S. Consul General, Chennai Keynote: Dr. C.N. Ashwath Narayan, Ministry for Electronics, Information Technology, Biotechnology, Science and Technology, Higher Education, Skill development, Entrepreneurship and Livelihood Government of Karnataka |
3:30 PM – 4:20 PM |
Panel Discussion |
Session: A Quad Strategic Technology Update: Partnership for the Century The U.S.-India strategic relationship continues to deepen and expand via the Quad and the U.S.-India Initiative on Critical and Emerging Technology (iCET). The Quad and the bilateral iCET mission cover cyber, artificial intelligence, quantum, 5G/6G communications, space hardware, biotechnology and quantum applications. Importantly, these new structures align government scientific investment in labs, industry, research institutes, academia with strategic R&D employed to create and promote critical national security technological priorities. The strategic relationship deepened recently with the announcement of collaboration between National Science Foundation and the Indian science and technological ecosystem. In addition, the Prime Minister of India, during his Independence Day Speech, called for a push in research and innovation. There is a wider realisation that R&D investments should be at par with Make in India policy. The collaboration across the U.S.-India corridor has massive potential to link our scientific and academic communities to reinforce our existing deep and diverse commercial and national security ties. Moderator: Mr. Jay Gullish, Executive Director, USIBC Panellists:
|
|
4:20 PM - 4:30 PM |
Keynote |
Session: Start-up LEAD-Talk - Indian Platform The SaaS Growth Flywheel: The cost of software is reducing with time. SaaS is facing sameness, commoditization & me-too competition. The good news is that there is also high adoption and demand. Speaker: Mr. Manoj Agarwal, Co-founder, XoxoDay |
4:30 PM - 5:20 PM |
Panel Discussion |
Session: The Reality of the Metaverse: Commerce, Ethics, Security, and Safety There is much exciting around the Metaverse and the transformative nature of the immersive experience that innovates new games, training, and communications products, as well as the advance equipment driving spatial audio, 3D visuals and tactical experiences. These emerging technologies and applications will further create new way to educate, advertise and sell goods and services. But at the same time, the Metaverse creates totally new cybersecurity and safety issues – requiring changes in both how to push of these technologies as well as how people learn to utilize them. From gaming to edutech, what are the killer Metaverse apps? What role will India play – from back-end R&D to consumer, education, and consumer usage? Our expert panels will answer these questions and more to help us understand the future of the Metaverse. Moderator: Dileep Srihari, Vice President & Senior Policy Counsel at Access Partnership Panellists:
|
5:20 PM - 5:35 PM |
Keynote |
Session: Tech LEAD Talk Digital Health Changing the Course of Healthcare Innovation Speaker:
|
5:35 PM - 6:25 PM |
Panel Discussion |
Session: Digital Health Changing the Course of Healthcare Innovation with Adoption, Evidence and Regulation as key drivers Digitization is revolutionizing health care, enabling health outcomes via patient reporting, and records keeping for radiographs, pathology images, etc. along with diagnostic tools available on mobiles and tablets. There are also Improvements in telemedicine, vaccine inventory management, effective healthcare delivery and expanding access advances in AI applications that help clinical decision-making. The panel will discuss how the industry and government can work together to build digital infrastructure and collaborate with tech partners in the U.S.-India corridor, enhance preparedness against outbreaks, harmonize standards for product innovations, reduce and R&D risks through better data analytics. Moderator: Ms. Bagmisikha Puhan, Associate Partner, Digital Health, TMT Law Practice Panelists:
|
Technology as a key driving force for India's Inclusive Development & Techade (Main Hall)
DAY 2 | THURSDAY | 17 NOVEMBER 2022 |
||
TIME |
SESSION # |
STATUS |
11:00 AM - 11.50 PM |
|
MoU signing ceremony between USIBC and USAID
|
|
Session: Plenary Technology as a key driving force for India's Inclusive Development Moderator: Tobby Simon, Founder & President, Synergia Foundation Panelists:
|
|
DAY 2 | THURSDAY | 17 NOVEMBER 2022 |
||
TIME |
SESSION # |
STATUS |
4:00 PM- 5.15 PM |
Panel Discussion |
Session: Augmenting and co-creating IP through US- India Partnership Innovation in the life science space, backed by collaboration on intellectual property (IP), can set the foundation for India and U.S. cooperation. Friction between cross-border innovation and conventional IP protection is pushing companies and start-ups alike to cultivate new IP management strategies that are responsive to the dual challenges of control and openness. Given the rising cost of R&D and innovation, we are seeing more IP co-ownership in information technology, automotives and medicine. In the backdrop, Covid 19 also demonstrated innovative pathways to collaborate on IP such as voluntary licencing for extended IP access, etc. The panel will discuss their experiences, best practices and evolving trends in the IP regimes in India and U.S. markets. Panelists will share suggestions on how enhance entrepreneurial, scientific activity and collaboration among start-ups as well within established companies. Moderator: Mr. Ravi Bhola, Partner & Patent Chair, K&S Partners Panelists:
|
5:15 PM - 6:30 PM |
Panel Discussion |
Session: What India needs to become a thriving healthcare R&D hub? Today's interconnected world calls for science-based partnerships and collaborations in a boundary-less manner. The mantra to sustain manufacturing and keep advancing product development to stay relevant in the market is through sustained investments in R&D activities and partnering with agile start-ups. R&D in emerging areas of biomedical innovations and therapeutics interventions are needed for fighting future diseases. For India to remain competitive, targeted investments in R&D in emerging areas of medical products and advanced therapeutics are needed as seen in the global pharma and MedTech product pipeline that will drive future growth of the sector. R&D is capital intensive, time consuming, and involves development of a research ecosystem. Research Linked Incentive can together act as an enabler to make India the R&D hub that will also support product design and improvement and will in turn boost manufacturing. The panel discussion will comprise industry experts and government policy makers who discuss the future of MedTech and biopharmaceuticals, and strategies for India to swiftly capitalize on and adapt to new technologies and cutting edge research Moderator: Dr. Vibhav Garg, Director, Health Economics & Government Affairs, India HUB & ASEAN, Boston Scientific Panelists:
|
